In humans, Notch4 triggers endothelial dysfunction in pre-eclampsia, and polymorphisms in Notch4 are associated with the severity of COVID-19–induced lung inflammation, thought to be mediated by endothelial activation (36, 37). This evidence concerns the gene NOTCH4 and COVID-19.